Conagra Brands news

Despite beating earnings estimates by 32.26%, the company received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends. The stock has significantly underperformed the market (down 18.4% vs. S&P 500 up 12.1% YTD), and the industry outlook is weak, ranking in the bottom 18% of sectors.

The company faces structural challenges including declining annual sales since 2023, a significant GAAP net loss in 2026, reduced adjusted net profit, and a dividend cut for the first time since 2006. The business model centered on frozen and prepared foods is misaligned with shifting consumer preferences toward healthier options. While modest expectations could allow for a beat, the fundamental trajectory remains downward with unclear strategic direction from new leadership.

The company faces multiple red flags including a 10.2% yield suggesting market expectations of a 50%+ dividend cut, adjusted earnings down 20% YoY, $4.5 billion in debt due 2026-2029, weak brand portfolio, and a newly appointed CEO likely to reset operations including potential dividend cuts. These factors indicate significant financial stress and downside risk for dividend investors.

The company exhibits weak financial performance with declining organic sales (-2.9% in fiscal 2025), significant earnings drops (nearly 14% decline), reduced earnings guidance, elevated leverage relative to peers, and a history of dividend cuts. The high dividend yield reflects market concerns about sustainability. The company is positioned as a second-tier competitor vulnerable to economic headwinds and changing consumer behavior.

Stock dropped 4% on CEO replacement announcement. Company has been struggling with poor performance and an outdated product portfolio of packaged foods that doesn't appeal to health-conscious consumers. The unexpected leadership change signals investor concern about the company's direction.

Stock hit 52-week low with 4.78% decline on announcement day. Company missed earnings expectations (39¢ vs 40¢ consensus), reported declining sales (-1.9% YoY), and narrowed full-year guidance below analyst estimates. Technical indicators show bearish trends with stock trading 18.1% below 50-day SMA. 12-month decline of 45.19% reflects ongoing market challenges.

Stock is trading at deep-value levels (9X price multiple vs. 18X historical average) with a 9% dividend yield. Technical indicators show strong support, institutional accumulation is aggressive, and the company maintains sufficient cash flow despite headwinds. Expected return to growth in fiscal 2027 and potential dividend increases provide catalysts for recovery, though near-term risks from private label competition and weak guidance persist.

Weak business performance with 3% organic sales decline, brand value write-downs, and ownership of second-tier brands. High dividend yield (8.9%) reflects market concerns about sustainability rather than strength.

The announcement of a consistent quarterly dividend payment of $0.35 per share demonstrates financial stability and commitment to shareholder returns. The company's 50-year history of consecutive quarterly dividends since 1976 reflects strong financial health and investor confidence.

Despite the positive $220 million investment in manufacturing capacity, the company's fundamentals are weak. Sales declined 6.8% with organic sales down 3% in Q2 2026, the company took brand value write-downs, it owns second-tier brands, and faces sector-wide headwinds. While the 8.6% dividend yield is attractive, it is not sustainable given weak earnings, making the stock unattractive for long-term investors compared to better-positioned alternatives.

Expected to report a 20.5% year-over-year decline in quarterly earnings per share ($0.31), with revenues projected to decline 1.5% from the year-ago quarter. The unchanged consensus estimate over 30 days suggests limited positive momentum heading into the earnings release.

In Q3 fiscal 2026, Conagra's sales dropped 1.9% and adjusted earnings per share fell 23.5%, showing that certain food categories are experiencing weakness amid consumer spending pressures.

Highest yield (9.7-9.9%) but carries significant risk. Payout ratio of 80%, no dividend increase last year, and weak frozen/packaged food volumes. GLP-1 drug impact and potential dividend cut risk make this a high-risk, deep-value play.

While offering a higher 9.9% yield, Conagra is less attractive due to material one-time charges, lower interest coverage ratio (3.5x), weaker brand portfolio of secondary brands, previous dividend cut in 2006, and lower gross margins (24.25%), making its dividend less secure despite adequate current coverage.

Extremely cheap valuation (9x forward P/E) and 9%+ yield are offset by significant structural challenges: GLP-1 adoption, SNAP cuts, private-label competition, and input costs. Dividend payout exceeds 80% of profits with little room to maneuver. New CEO appointment suggests management change needed, with precedent for dividend cuts (34% cut in 2006).

Stock down 42% in one year, hit 17-year low, declining revenue for three consecutive fiscal years, falling operating profits, multiple goodwill impairments, trailing gross margin at 14-year low, stopped dividend increases in 2023, payout ratio unsustainable at 82%, and facing headwinds from GLP-1 weight loss drugs reducing consumer demand.

Successfully using AI to rationalize brand portfolio and focus on high-performing categories. Attractive 9% dividend yield with strong positioning in frozen meals and shelf-stable staples for home consumption trends.

Stock declined nearly 60% over five years amid weak growth, GLP-1 drug headwinds, rising food costs, and elevated oil prices. High dividend yield of 9% is questioned as potentially unsustainable. Described as riskiest of the three stocks.

Already experiencing significant margin pressure with adjusted operating margin down 210 basis points year-over-year in Q3 2026. Will need to raise prices quickly to protect margins amid rising ingredient and transportation costs.

Facing margin compression from rising fertilizer and transportation costs; already experiencing declining operating margins (10.6% vs 12.7% prior year) and will need to pass costs to consumers.

Natural gas used to produce fertilizer; rising energy costs increase ingredient costs; limited pricing power with budget-conscious consumers

Now has highest S&P 500 dividend yield at 7.4%, maintains payout ratio around 80% of earnings (within reasonable range), showing positive business momentum with expected sales growth in second half of fiscal year, and has reduced debt by over 10% in the past year, strengthening financial foundation.

Declining sales (-6.8%), falling earnings, deteriorating free cash flow ($113M vs $426M year-ago), elevated payout ratio (80% vs 50-55% target), high leverage (3.8x vs 3.0x target), and inability to cover dividends from operating cash flow. High yield is driven by stock price decline, signaling financial distress rather than strength.

Stock down 50% over three years creating a bargain valuation at 11x forward earnings (vs S&P 500 at 22x). Highest dividend yield in S&P 500 at 7.3%. Strong cash flow supports dividend maintenance despite elevated payout ratio. Positioned for recovery as market conditions improve.